European Code Against Cancer and scientific justification: third version (2003). (Q33967068)

30 July 2017

European Code Against Cancer and scientific justification: third version (2003). (English)

1 reference

30 July 2017

1

1 reference

30 July 2017

21

1 reference

30 July 2017

36

T Tursz

0 references

Hans H Storm

H Storm

34

0 references

Philippe Autier

P Autier

2

0 references

Patrick Maisonneuve

P Maisonneuve

24

0 references

Stener Kvinnsland

20

S Kvinnsland

1 reference

30 July 2017

4

J Baselga

1 reference

30 July 2017

5

P Boffetta

1 reference

30 July 2017

13

S Franceschi

1 reference

30 July 2017

42

H zur Hausen

1 reference

30 July 2017

41

W Zatonski

1 reference

30 July 2017

Julia A Newton Bishop

26

J Newton Bishop

1 reference

30 July 2017

H Bartelink

3

1 reference

30 July 2017

J Burn

6

1 reference

30 July 2017

H J G Burns

7

1 reference

30 July 2017

L Christensen

8

1 reference

30 July 2017

L Denis

9

1 reference

30 July 2017

M Dicato

10

1 reference

30 July 2017

V Diehl

11

1 reference

30 July 2017

R Doll

12

1 reference

30 July 2017

C R Gillis

14

1 reference

30 July 2017

N Gray

15

1 reference

30 July 2017

L Griciute

16

1 reference

30 July 2017

A Hackshaw

17

1 reference

30 July 2017

M Kasler

18

1 reference

30 July 2017

M Kogevinas

19

1 reference

30 July 2017

F Levi

22

1 reference

30 July 2017

J G McVie

23

1 reference

30 July 2017

J M Martin-Moreno

25

1 reference

30 July 2017

F Oleari

27

1 reference

30 July 2017

P Perrin

28

1 reference

30 July 2017

M Quinn

29

1 reference

30 July 2017

M Richards

30

1 reference

30 July 2017

U Ringborg

31

1 reference

30 July 2017

C Scully

32

1 reference

30 July 2017

E Siracka

33

1 reference

30 July 2017

M Tubiana

35

1 reference

30 July 2017

U Veronesi

37

1 reference

30 July 2017

N Wald

38

1 reference

30 July 2017

W Weber

39

1 reference

30 July 2017

D G Zaridze

40

1 reference

30 July 2017

1 July 2003

1 reference

30 July 2017

1 reference

30 July 2017

14

1 reference

30 July 2017

973-1005

1 reference

30 July 2017

7

1 reference

Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas

30 July 2017

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Effect of sulindac on sporadic colonic polyps.

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia.

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

A randomized trial of a low fat high fibre diet in the recurrence of colorectal polyps. Toronto Polyp Prevention Group

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

European School of Oncology Advisory report to the European Commission for the "Europe Against Cancer Programme" European Code Against Cancer

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Epidemiology of prostate cancer chemoprevention

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

A mathematical model for the age distribution of cancer in man

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Overview of the main outcomes in breast-cancer prevention trials

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

The chemotherapy of colon cancer can no longer be ignored

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants.

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Improving prognosis of Hodgkin's disease in Scotland

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Cancer incidence in Asian migrants to New South Wales, Australia

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy

1 reference

8 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1093/ANNONC/MDG305

Identifiers

DOI

10.1093/ANNONC/MDG305

1 reference

30 July 2017

1 reference